Keyphrases
Safety Efficacy
100%
Long-term Safety
100%
Topiramate
100%
Sustained Efficacy
100%
Extended-release Capsules
100%
Partial Seizures
100%
Open-label Extension
80%
Treatment-related Adverse Events
60%
Seizure Frequency
60%
Adjunctive Therapy
40%
Neurocognitive
40%
QOLIE-31-P
40%
Seizure-free
40%
Treatment Options
20%
Placebo
20%
Effective Treatment
20%
Adult Patients
20%
Clinical Status
20%
Treatment Phase
20%
Quality of Life
20%
Percentage Reduction
20%
Treatment Duration
20%
Tolerability
20%
Multidrug-resistant
20%
Safe Treatment
20%
Safety Quality
20%
Long-term Efficacy
20%
Drug Seizures
20%
Patient Global Impression of Change
20%
Quality of Life in Epilepsy
20%
Qudexy XR
20%
Patient Subgroups
20%
Responder Rate
20%
Free Interval
20%
Seizure Reduction
20%
Life Safety
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Topiramate
100%
Placebo
33%
Tolerability
33%